相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial
Giancarlo Comi et al.
LANCET NEUROLOGY (2012)
Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis
T. Chitnis et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Management of Pediatric Central Nervous System Demyelinating Disorders: Consensus of United States Neurologists
Amy T. Waldman et al.
JOURNAL OF CHILD NEUROLOGY (2011)
The management of multiple sclerosis in children: a European view
Angelo Ghezzi et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
G. Comi et al.
LANCET (2009)
Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States
T. Chitnis et al.
MULTIPLE SCLEROSIS (2009)
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience
Angelo Ghezzi et al.
NEUROLOGICAL SCIENCES (2009)
Effectiveness of early beta interferon on the first attack after confirmed multiple sclerosis: A comparative cohort study
Yann Mikaeloff et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2008)
Natural history of multiple sclerosis with childhood onset
Christel Renoux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment of early-onset multiple sclerosis with intramuscular interferonβ-1a:: long-term results
A. Ghezzi et al.
NEUROLOGICAL SCIENCES (2007)
Treatment of pediatric multiple sclerosis and variants
D. Pohl et al.
NEUROLOGY (2007)
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
L. Kappos et al.
NEUROLOGY (2006)
Prognostic factors for early severity in a childhood multiple sclerosis cohort
Yann Mikaeloff et al.
PEDIATRICS (2006)
Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis
Silvia N. Tenembaum et al.
NEUROLOGY (2006)
Natural history of multiple sclerosis: a unifying concept
C Confavreux et al.
BRAIN (2006)
Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis
B Banwell et al.
NEUROLOGY (2006)
Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a
D Pohl et al.
NEUROLOGY (2005)
The use of interferon beta in relapsing-remitting multiple sclerosis
LJ Etheridge et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2004)
Multiple sclerosis in children under 10 years of age
M Ruggieri et al.
NEUROLOGICAL SCIENCES (2004)
Contrasting effects of IFNβ and IVIG in children with central and peripheral demyelination
I Pirko et al.
NEUROLOGY (2003)
Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a - Incidence and clinical significance
GS Francis et al.
DRUG SAFETY (2003)
Course and prognosis in early-onset MS - Comparison with adult-onset forms
IL Simone et al.
NEUROLOGY (2002)
Randomized, comparative study of interferon β-1a treatment regimens in MS -: The EVIDENCE trial
H Panitch et al.
NEUROLOGY (2002)
Early onset multiple sclerosis - A longitudinal study
A Boiko et al.
NEUROLOGY (2002)
Interferon-β treatment in patients with childhood onset multiple sclerosis
Y Mikaelloff et al.
JOURNAL OF PEDIATRICS (2001)
Effect of early interferon treatment on conversion to definite multiple sclerosis:: a randomised study
G Comi et al.
LANCET (2001)
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis.
LD Jacobs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
